Featured post

#Avian #Influenza #H7N9 in #China: Preventing the Next #SARS (@WHO, Apr. 2 ‘17)

  Title : #Avian #Influenza #H7N9 in #China: Preventing the Next #SARS. Subject : Avian Influenza, H7N9 subtype (Asian Lineage), poultry e...

3 Oct 2016

#Influenza and other #Respiratory #Viruses #Research #References #Library–October 3 2016 Issue


Title: #Influenza and other #Respiratory #Viruses #Research #References #Library–October 3 2016 Issue.

Subject: Human and Animal Influenza Viruses, other Respiratory Pathogens Research, weekly references library update.

Source: AMEDEO, homepage: (LINK).

Code: [  R  ]


This Week’s References:


  1. UCHIDA Y, Kanehira K, Takemae N, Hikono H, et al.
  2. KAEWBORISUTH C, Kaplan B, Zanin M, Finkelstein D, et al.
    • G45R on nonstructural protein 1 of influenza A virus contributes to virulence by increasing the expression of proinflammatory cytokines in mice.
  3. DELABRE RM, Salez N, Lapidus N, Lemaitre M, et al.
  4. HE F, Lin JF, Wang XY, Li FD, et al.
    • Quantitative risk analysis of the novel H7N9 virus in environments associated with H9 avian influenza virus, Zhejiang province, China.
  5. MOSS R, Zarebski A, Dawson P, McCAW JM, et al.
  6. TAYLOR S, Lopez P, Weckx L, Borja-Tabora C, et al.
    • Respiratory viruses and influenza-like illness: epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample.
  7. NELSON MI, Stucker KM, Schobel SA, Trovao NS, et al.
  8. SUN X, Belser JA, Pulit-Penaloza JA, Zeng H, et al.
    • Pathogenesis and transmission assessments of two H7N8 influenza A viruses recently isolated from turkey farms in Indiana using mouse and ferret models.
  9. KIRUI J, Mondal A, Mehle A.
  10. HOFFMANN A, Schade D, Kirchmair J, Clement B, et al.
    • Platform for determining the inhibition profile of neuraminidase inhibitors in an influenza virus N1 background.
  12. BLACK CL, Yue X, Ball SW, Donahue SM, et al.
  14. FITZGERALD TJ, Kang Y, Bridges CB, Talbert T, et al.
    • Integrating pharmacies into public health program planning for pandemic influenza vaccine response.
  15. GELLIN BG, Qadri F.
  16. LIN X, Fiebelkorn AP, Pabst LJ.
    • Trends in compliance with two-dose influenza vaccine recommendations in children aged 6 months through 8 years, 2010-2015.
  17. WILLIS E, Parkhouse K, Krammer F, Hensley SE, et al.
    • Canine H3N8 influenza vaccines partially protect mice against the canine H3N2 strain currently circulating in the United States.
  18. LEVIN Y, Kochba E, Shukarev G, Rusch S, et al.
    • A phase 1, open-label, randomized study to compare the immunogenicity and safety of different administration routes and doses of virosomal influenza vaccine in elderly.
  19. WONG VW, Fong DY, Lok KY, Wong JY, et al.
  20. SLAUNWHITE JM, Smith SM, Halperin BA, Langley JM, et al.
    • The role of healthcare provider attitudes in increasing willingness to accept seasonal influenza vaccine policy changes.
  21. PUSHKO P, Sun X, Tretyakova I, Hidajat R, et al.
    • Mono- and quadri-subtype virus-like particles (VLPs) containing H10 subtype elicit protective immunity to H10 influenza in a ferret challenge model.
  22. BATES JT, Pickens JA, Schuster JE, Johnson M, et al.
    • Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates.
  23. KRISTENSEN M, van Lier A, Eilers R, McDonald SA, et al.
  24. DETERMANN D, de Bekker-Grob EW, French J, Voeten HA, et al.
  25. CUI P, Deng G, Shi J, Kong H, et al.


Keywords: Research; Abstracts; Influenza References Library.